The trailer for the highly anticipated Malayalam web series Pharma has finally dropped, marking the digital debut of popular actor Nivin Pauly. The medical drama, which promises a hard-hitting look at the dark underbelly of the drug manufacturing sector, is scheduled for a multi-language premiere on December 19.
A Medical Rep's Moral Crisis
In the newly released preview, Nivin Pauly steps into the shoes of KP Vinod, a medical sales representative struggling to meet his targets. Guided by a senior, played by Binu Pappu, Vinod's initial difficulties suggest he might be in the wrong line of work. His fortunes appear to change when he successfully promotes a new medication named KydoXin.
However, the trailer takes a dramatic turn when Vinod discovers the devastating truth: the drug he has been pushing is dangerous and has already caused significant harm to patients. This revelation propels the protagonist into a fierce battle against the very industry he works for.
Star-Studded Cast and Multi-Language Release
Pharma boasts a powerful ensemble cast featuring seasoned actors in key roles. Alongside Nivin Pauly and Binu Pappu, the series stars Rajit Kapur, Narain, Shruti Ramachandran, Veena Nandakumar, Muthumani, and Aalekh Kapoor.
The series is written and directed by PR Arun. To ensure a wide reach, the makers have announced a simultaneous premiere in seven Indian languages. Viewers can watch Pharma on JioCinema from December 19 in Malayalam, Hindi, Tamil, Telugu, Kannada, Bengali, and Marathi.
What's Next for Nivin Pauly?
While fans eagerly await his OTT debut, Nivin Pauly has a busy slate of film projects lined up. His next big-screen appearance will be in Sarvam Maya, directed by Akhil Sathyan, which is set for a theatrical release on December 25.
The actor's pipeline also includes other promising titles such as Dear Students, Baby Girl, and Yezhu Kadal Yezhu Malai, keeping his audience engaged across platforms.
The release of the Pharma trailer has sparked considerable conversation online, with many praising its relevant subject matter and Nivin Pauly's compelling performance. It positions itself as a bold narrative aiming to uncover unethical practices in a powerful global industry.
